Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

glipiZIDE-metFORMIN

glipiZIDE-metFORMIN
  • Non-formulary
  • Therapeutic Interchange
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Metaglip TABLET, ORAL 2.5 mg-250 mg, 2.5 mg-500 mg    
Comments:

Ordered Formulation

Therapeutic Interchange

glipiZIDE-metFORMIN (Metaglip)

  • 2.5 mg-250 mg tablet oral                                                                                                                   
  • 2.5 mg-500 mg tablet oral

glipiZIDE (Glucotrol) AND metFORMIN (Glucophage)

  • 2.5 mg glipiZIDE tablet PLUS ONE 250 mg metFORMIN
  • 2.5 mg glipiZIDE tablet PLUS ONE 500 mg metFORMIN

metFORMIN -- hold for 48 hours post IV contrast media per radiologist, contraindications with CHF, renal disease, hepatic disease, and age. Pharmacist may order SCr.

Last updated: Dec. 15, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved